<DOC>
	<DOCNO>NCT03021759</DOCNO>
	<brief_summary>In study , investigator conduct pragmatic , cluster-randomized , controlled trial evaluate active choice intervention without social comparison feedback increase physician statin prescribe rate eligible patient .</brief_summary>
	<brief_title>Pragmatic , Randomized Evaluation Statin Active Choice Reach Improved Outcomes Based Evidence</brief_title>
	<detailed_description>Cardiovascular disease ( CVD ) lead cause morbidity mortality United States . Strong evidence indicate statin medication reduce risk CVD CVD statins show reduce mortality . Despite evidence , statins under-prescribed . In study , investigator test effectiveness nudge target physician use active choice social comparison feedback increase rate statin medication prescribe patient eligible base national practice guideline .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Patient primary care physician University Pennsylvania Health System Patient meet 2013 AHA/ACC guideline statin therapy record statin prescription electronic health record Patient allergy adverse reaction statin document electronic health record Patient glomerular filtration rate le 30 mL/min Physicians ( respective patient ) exclude less 10 patient among entire panel eligible statin</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>